CTSI: Physical Activity and Cognition Study

Sponsor
Boston University (Other)
Overall Status
Completed
CT.gov ID
NCT02773121
Collaborator
(none)
28
1
2
34.6
0.8

Study Details

Study Description

Brief Summary

The goal of this research study is to examine whether an intervention to increase physical activity using a body-worn sensor affects cognitive (thinking) processes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Physical Activity
N/A

Detailed Description

The overall duration of participation in this research study is approximately 4 months. During this time, three study visits will be required. The first visit is for informed consent and screening, the second visit is for baseline fitness and cognitive testing, and the third visit is for follow-up fitness and cognitive testing after a 12-week physical activity monitoring program. Participants will be randomized to one of two study arms, a physical activity monitoring arm and a flexibility and balance arm. Both study arms involve wearing a physical activity sensor and monitoring physical activity for a duration of 12 weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Feasibility of Using Physical Activity Monitoring for Enhancing Cognition in Healthy Seniors
Actual Study Start Date :
Mar 1, 2017
Actual Primary Completion Date :
Jan 17, 2020
Actual Study Completion Date :
Jan 17, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Physical activity monitoring

Participants will wear a physical activity sensor on the hip or waist with a belt. They will be instructed to increase their physical activity level to at least 150 min of moderate-intensity physical activity per week. They will be asked to follow guidelines in the "Go4Life" brochure, website, and/or videos by the National Institute on Aging. Participants will receive weekly phone calls to monitor their progress, to provide feedback, and to suggest example exercises.

Behavioral: Physical Activity
Trainer-guided at-home behavioral intervention

Active Comparator: Flexibility and balance

Participants will wear a physical activity sensor on the hip or waist with a belt. They will be instructed to increase their balance and flexibility over the 12 week period of the intervention. They will be asked to follow guidelines in the "Go4Life" brochure, website, and/or videos by the National Institute on Aging. Participants will receive weekly phone calls to monitor their progress, to provide feedback, and to suggest example exercises.

Behavioral: Physical Activity
Trainer-guided at-home behavioral intervention

Outcome Measures

Primary Outcome Measures

  1. Cognition [80-90 minutes]

    Change in cognitive task performance post-intervention compared to baseline

  2. Aerobic Fitness [30 minutes]

    Change aerobic fitness measured with treadmill test post-intervention

Secondary Outcome Measures

  1. Functional fitness: Five Times Sit to Stand [10 min]

    Change in performance in the Five Times Sit to Stand test post-intervention

  2. Functional fitness: Timed Get Up and Go [10 min]

    Change in performance in the Timed Get Up and Go test post-intervention compared to baseline

  3. Functional fitness: Flexibility [10 min]

    Change in performance in the Sit and Reach test post-intervention

  4. Physical activity [12 weeks]

    Greater overall moderate-intensity physical activity time and step count and lower sedentary time in the physical activity monitoring than the flexibility and balance group

Other Outcome Measures

  1. Gait: step and stride time [12 weeks]

    Change in step and stride time over 12 weeks

  2. Gait: stride time variability [12 weeks]

    Change in stride time variability over 12 weeks

  3. Gait: gait symmetry [12 weeks]

    Change in gait symmetry over 12 weeks

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Non-smoking

  • Age between 55-85 years

  • Sedentary status (physically inactive; not participating in at least 30 minutes of moderate intensity physical activity on at least three days per week for at least three months)

  • Generally healthy men and women

  • Living in the greater Boston area

  • Available for the 4 month duration of the study

  • Native-English speaking or fluent in English (must have attended elementary school and higher in English)

Exclusion Criteria:
  • Poor vision that cannot be corrected with glasses or contact lenses

  • Presence of an acute infection

  • Diagnosis of kidney failure

  • Diagnosis of liver disease

  • Diagnosis of thyrotoxicosis/hyperthyroidism

  • Diagnosis of cancer

  • Past or present conditions that affect cognitive functioning:

  1. learning disability

  2. neurological disorders or conditions (movement disorder, history of head trauma or stroke, epilepsy, etc.)

  3. psychiatric disorders or conditions (depression, anxiety disorder, etc.)

  • Past or present conditions that are counter indicators for participation in cardio-respiratory fitness assessment and moderate-intensity physical activity:
  1. heart conditions (e.g. heart attack, arrhythmias, etc.)

  2. circulatory conditions (e.g. uncontrolled hypertension, leg claudication, high cholesterol, etc.)

  3. respiratory conditions (e.g., asthma or lung conditions, such as chronic obstructive pulmonary disease, acute bronchitis, acute common cold, lung cancer, pneumonia, etc.)

  4. current musculoskeletal impairments (e.g. fractures, hemiplegia, chronic joint pain, arthritis, osteoporosis, not able to walk comfortably without assistance, etc.)

  5. diagnosis of electrolyte disorder or abnormality

  6. presence of diabetes mellitus

  • Obesity

  • Prescription medication or other drugs that treat heart, lung, or circulatory conditions (e.g. beta blockers, bronchodilators, etc.)

  • Prescription medication or other drugs that affect chemicals in the brain (e.g. antidepressants, anxiolytics, etc.)

  • Implanted medical devices, such as a pacemaker or defibrillator

  • Unavailable for the approx. 4-month duration of the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Boston University School of Medicine Boston Massachusetts United States 02118

Sponsors and Collaborators

  • Boston University

Investigators

  • Principal Investigator: Karin Schon, Ph.D., Boston University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Boston University
ClinicalTrials.gov Identifier:
NCT02773121
Other Study ID Numbers:
  • H-34352
First Posted:
May 16, 2016
Last Update Posted:
Apr 21, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Boston University

Study Results

No Results Posted as of Apr 21, 2020